Federal Register / Vol. 86, No. 29 / Tuesday, February 16, 2021 / Notices 9535 

1The record is defined in § 207.2(f) of the 

Commission’s Rules of Practice and Procedure (19 

CFR 207.2(f)). 

must offer you the opportunity to appeal 

the decision in accordance with the 

agency’s procedures. If the agency has 

received and acted upon or will act 

upon a SAVE verification and you do 

not believe the response is correct, you 

may make an appointment for an inperson interview at a local USCIS office. 

Detailed information on how to make 

corrections or update your immigration 

record, make an appointment, or submit 

a written request to correct records 

under the Freedom of Information Act 

can be found on the SAVE website at 

www.uscis.gov/save. 

Tracy L. Renaud, 

Senior Official Performing the Duties of the 

Director, U.S. Citizenship and Immigration 

Services. 

[FR Doc. 2021–03149 Filed 2–12–21; 8:45 am] 

BILLING CODE P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 337–TA–1226] 

Certain Artificial Eyelash Extension 

Systems, Products, and Components 

Thereof; Commission Determination 

Not To Review an Initial Determination 

Granting Complainant’s Motion for 

Leave To Amend the Complaint and 

Notice of Investigation 

AGENCY: U.S. International Trade 

Commission. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that 

the U.S. International Trade 

Commission has determined not to 

review an initial determination (‘‘ID’’) 

(Order No. 10) of the presiding 

administrative law judge (‘‘ALJ’’) 

granting the complainant’s motion for 

leave to amend the complaint and 

notice of investigation. 

FOR FURTHER INFORMATION CONTACT: 

Lynde Herzbach, Office of the General 

Counsel, U.S. International Trade 

Commission, 500 E Street SW, 

Washington, DC 20436, telephone (202) 

205–3228. Copies of non-confidential 

documents filed in connection with this 

investigation may be viewed on the 

Commission’s electronic docket (EDIS) 

at https://edis.usitc.gov. For help 

accessing EDIS, please email 

EDIS3Help@usitc.gov. General 

information concerning the Commission 

may also be obtained by accessing its 

internet server at https://www.usitc.gov. 

Hearing-impaired persons are advised 

that information on this matter can be 

obtained by contacting the 

Commission’s TDD terminal on (202) 

205–1810. 

SUPPLEMENTARY INFORMATION: On 

October 28, 2020, the Commission 

instituted this investigation under 

section 337 of the Tariff Act of 1930, as 

amended, 19 U.S.C. 1337 (‘‘section 

337’’), based on a complaint filed by 

Lashify, Inc. of Glendale, California 

(‘‘Complainant’’). See 85 FR 68366–67. 

The complaint, as supplemented, 

alleges a violation of section 337 based 

upon the importation into the United 

States, sale for importation, or sale after 

importation into the United States of 

certain artificial eyelash extension 

systems, products, and components 

thereof by reason of infringement of 

certain claims of U.S. Patent Nos. 

10,660,388 and 10,721,984 and U.S. 

Design Patent Nos. D877,416 and 

D867,664. The complaint also alleges 

the existence of a domestic industry. 

The notice of investigation names nine 

respondents, including CVS Health 

Corporation of Woonsocket, Rhode 

Island and Ulta Beauty, Inc. of 

Bolingbrook, Illinois. See id. The Office 

of Unfair Import Investigations is also a 

party to the investigation. See id. 

On January 8, 2021, Complainant filed 

a motion seeking leave to amend the 

complaint and notice of investigation to 

substitute: (1) CVS Pharmacy, Inc. in 

place of CVS Health Corporation and (2) 

Ulta Salon, Cosmetics & Fragrance, Inc. 

in place of Ulta Beauty, Inc. No 

responses to the motion were filed. 

On January 22, 2021, the ALJ issued 

the subject ID (Order No. 10) granting 

Complainant’s motion for leave to 

amend the complaint and notice of 

investigation to reflect the substitutions. 

Order No. 10 (Jan. 22, 2021). The subject 

ID finds that Complainant’s motion is 

supported by good cause pursuant to 

Commission Rule 210.14(b) (19 CFR 

210.14(b)) and that there is no prejudice 

if the motion is granted. No party 

petitioned for review of the subject ID. 

The Commission has determined not 

to review the subject ID. CVS Pharmacy, 

Inc. and Ulta Salon, Cosmetics & 

Fragrance, Inc. are named as 

respondents in this investigation; and 

CVS Health Corporation and Ulta 

Beauty, Inc. are terminated from the 

investigation. 

The Commission vote for this 

determination took place on February 

10, 2021. 

The authority for the Commission’s 

determination is contained in section 

337 of the Tariff Act of 1930, as 

amended (19 U.S.C. 1337), and in Part 

210 of the Commission’s Rules of 

Practice and Procedure (19 CFR part 

210). 

By order of the Commission. 

Issued: February 10, 2021. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2021–03059 Filed 2–12–21; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 731–TA–1059 (Third 

Review)] 

Hand Trucks and Certain Parts Thereof 

From China 

Determination 

On the basis of the record 1 developed 

in the subject five-year review, the 

United States International Trade 

Commission (‘‘Commission’’) 

determines, pursuant to the Tariff Act of 

1930 (‘‘the Act’’), that revocation of the 

antidumping duty order on hand trucks 

and certain parts thereof from China 

would be likely to lead to continuation 

or recurrence of material injury to an 

industry in the United States within a 

reasonably foreseeable time. 

Background 

The Commission instituted this 

review on July 1, 2020 (85 FR 39584) 

and determined on October 5, 2020 that 

it would conduct an expedited review 

(86 FR 2001, January 11, 2021). 

The Commission made this 

determination pursuant to section 

751(c) of the Act (19 U.S.C. 1675(c)). It 

completed and filed its determination in 

this review on February 9, 2021. The 

views of the Commission are contained 

in USITC Publication 5159 (February 

2021), entitled Hand Trucks and Certain 

Parts Thereof from China: Investigation 

No. 731–TA–1059 (Third Review). 

By order of the Commission. 

Issued: February 9, 2021. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2021–02975 Filed 2–12–21; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–784] 

Importer of Controlled Substances 

Application: S and B Pharma, Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 


khammond on DSKJM1Z7X2PROD with NOTICES